Company intelligence / Profile preview

Longevir

Schiphol-Rijk, North Holland, Netherlands

Ownership: Private
Development stage: Other

Overview

Longevir is a European-based bulk supplement manufacturer and supplier specializing in high-purity longevity and anti-aging ingredients. Operating under Borealis Pharma Manufacturing B.V., the company is the first in Europe to produce Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR) using a 100% enzymatic process without chemical solvents. Longevir provides pharmaceutical-grade ingredients to B2B partners, offering white-label solutions, bulk powder, and encapsulated products featuring advanced gastro-resistant and liposomal delivery technologies. The company emphasizes EU GMP compliance, third-party purity testing, and environmental sustainability in its manufacturing processes.

Therapeutic areas: NeurologyOtherMetabolic Disorders
Modalities: Small moleculeLiposomal delivery therapyHydrogel-based drug delivery therapy
Industry: Food & Nutrition

Partnerships

AVEAPurovitalisFor YouthDoNotAge.org

Beyond the preview

Go deeper on Longevir.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Longevir.

Explore the full profile